News headlines about MedAssets (NASDAQ:MDAS) have been trending somewhat positive recently, according to Accern. The research group identifies negative and positive press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. MedAssets earned a coverage optimism score of 0.06 on Accern’s scale. Accern also gave press coverage about the technology company an impact score of 47.1541492709471 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
MedAssets, Inc (MedAssets) provides technology-enabled products and services to healthcare organizations, including hospitals, health systems, non-acute healthcare providers, payers, other service providers and product manufacturers. The Company operates its business through two business segments: Spend and Clinical Resource Management (SCM) and Revenue Cycle Management (RCM).
Receive News & Ratings for MedAssets Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedAssets Inc. and related companies with MarketBeat.com's FREE daily email newsletter.